Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 and glycaemic state effects on gastric emptying in healthy volunteers
ACTRN12613001384741Phase 3Completed
- Sponsor
- Dr Mark Plummer
- Start
- Sep 2013
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of Glucagon-like peptide 1 (4 arms), sponsored by Dr Mark Plummer. Primary endpoint: Gastric emptying. Started Sep 2013; status: completed.
02
Drugs
Glucagon-like peptide 1
Beyond the preview
Go deeper on ACTRN12613001384741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001384741.